SMEI(SZ:300456)2023-04-26 16:00Revenue and Profitability - Revenue for the first quarter reached ¥190,688,121.01, an increase of 10.07% compared to ¥173,237,171.77 in the previous year[2] - Net profit attributable to shareholders decreased by 34.63% to ¥15,429,627.46 from ¥23,605,221.18 year-over-year[2] - The company reported a basic and diluted earnings per share of ¥0.0210, a decrease of 34.86%[26] - The net profit for the first quarter was CNY 5,273,516.70, a significant increase of 178.52% compared to CNY 1,893,417.99 in the previous year[63] - The comprehensive income attributable to the parent company was CNY 14,739,881.39, compared to a loss of CNY 13,403,805.45 in the previous year[58] Cash Flow and Financial Position - The net cash flow from operating activities was ¥27,076,946.45, down 26.35% from ¥36,765,242.55 in the same period last year[2] - Cash and cash equivalents at the end of the period were ¥1,227,376,565.99, down from ¥2,355,347,761.49 at the end of the previous year[17] - The company reported a net cash flow from financing activities of CNY 138,184,743.61, an increase of 1331.02% compared to the previous period, driven by various factors[39] - The company's cash and cash equivalents at the end of the period were CNY 1,227,376,565.99, a decrease of 47.89% from the previous period[39] - The net cash inflow from operating activities was ¥262,492,062.53, down from ¥359,483,328.61 in the previous year, showing a decrease of approximately 27%[81] Assets and Liabilities - The total assets at the end of the reporting period were ¥6,987,525,248.02, reflecting a slight increase of 0.15% from ¥6,976,772,445.36 at the end of the previous year[2] - The total liabilities decreased slightly to ¥1,445,802,117.87 from ¥1,472,897,695.71, indicating a reduction in financial obligations[77] - The total current assets at the end of the period included cash and cash equivalents of CNY 1,241,819,726.46, down from CNY 1,522,340,087.78 at the beginning of the year[51] - Long-term borrowings increased by 54.17% to ¥376,950,000.00 primarily due to the acquisition of a semiconductor industrial park in Sweden[24] - The company's total liabilities decreased, with current liabilities totaling CNY 2,289,370,454.18, down from CNY 2,589,825,775.86[52] Investments and R&D - The company initiated small-scale trial production of a MEMS biosensor chip after customer validation in January 2023[5] - Research and development expenses rose by 36.80% to CNY 85,315,206.04 from CNY 62,364,220.84, indicating a strong focus on innovation[63] - The company completed the registration of a new investment fund in February 2023, enhancing its strategic investment capabilities[70] - The company reported a net loss from investments of ¥1,866,637.42, a significant decline compared to a gain of ¥74,140,503.46 in the previous year[78] Shareholder and Equity Information - The number of common shareholders at the end of the reporting period was 59,651, with the largest shareholder holding 25.81%[28] - The total equity attributable to shareholders increased to ¥5,029,092,927.14 from ¥4,981,088,435.88, reflecting a growth of approximately 1%[78] - The company plans to repurchase and cancel a total of 1,063,000 restricted shares, including 963,000 shares that have been granted but not yet released from restrictions and 100,000 shares from a previous resolution[72] Other Financial Metrics - The company reported a substantial increase in other income, which rose by 1905.63% to CNY 46,883,166.44 from CNY 2,337,580.99[63] - Non-recurring gains and losses totaled ¥28,548,706.17 after tax effects and minority interests[34] - The company received government subsidies amounting to ¥46,815,051.54 during the reporting period[34] - The company received a tax refund of CNY 15,473,875.73, an increase of 198.07% compared to the previous period due to VAT refunds received during the reporting period[38]